P3 Health Financials
PIII Stock | USD 0.17 0.01 6.25% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.85 | 0.64 |
|
|
The essential information of the day-to-day investment outlook for P3 Health includes many different criteria found on its balance sheet. An individual investor should monitor P3 Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in P3 Health.
Net Income |
|
PIII | Select Account or Indicator |
P3 Health Stock Summary
P3 Health competes with Sonida Senior, Acadia Healthcare, CryoCell International, Community Health, and Lifestance Health. P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. P3 Health operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 523 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US7444131053 |
CUSIP | 744413105 34552Y106 |
Location | Illinois; U.S.A |
Business Address | 2370 Corporate Circle, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | p3hp.org |
Phone | 702 910 3950 |
Currency | USD - US Dollar |
P3 Health Key Financial Ratios
Return On Equity | -0.65 | ||||
Profit Margin | (0.07) % | ||||
Operating Margin | (0.31) % | ||||
Price To Sales | 0.06 X | ||||
Revenue | 1.27 B |
P3 Health Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 99.9M | 2.4B | 876.6M | 861.0M | 990.1M | 938.8M | |
Other Current Liab | 78.7M | 177.4M | 230.1M | 290.7M | 334.3M | 175.5M | |
Net Debt | 12.9M | (50.6M) | 88.4M | 85.6M | 98.5M | 103.4M | |
Retained Earnings | (126.2M) | (39.4M) | (309.5M) | (367.3M) | (330.6M) | (314.1M) | |
Accounts Payable | 9.6M | 17.7M | 11.5M | 8.7M | 10.0M | 11.3M | |
Cash | 36.3M | 140.5M | 17.5M | 36.3M | 32.7M | 42.1M | |
Long Term Debt | 45.4M | 80M | 94.4M | 108.3M | 124.6M | 75.5M | |
Net Receivables | 45.6M | 52.1M | 79.6M | 121.5M | 139.7M | 146.7M | |
Other Current Assets | 9.0M | 7.3M | 3.6M | 4.6M | 5.3M | 5.8M | |
Total Liab | 146.0M | 299.9M | 353.9M | 427.3M | 491.4M | 286.2M | |
Net Invested Capital | (34.0M) | 357.2M | 100.3M | 250.4M | 288.0M | 302.4M | |
Total Current Assets | 84.3M | 199.9M | 100.7M | 166.0M | 190.9M | 132.7M | |
Capital Stock | 45.6M | 23.8K | 24K | 32K | 28.8K | 27.4K | |
Net Working Capital | (6.3M) | 1.1M | (141.0M) | (133.4M) | (120.0M) | (114.0M) | |
Short Term Debt | 2.3M | 3.6M | 3.6M | 2.7M | 3.1M | 3.0M | |
Common Stock | 97.2M | 23.8K | 24K | 32K | 28.8K | 27.4K |
P3 Health Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Net Interest Income | (3.5M) | (10.0M) | (11.4M) | (14.9M) | (13.4M) | (12.8M) | |
Interest Expense | 2.5M | 2.5M | 11.4M | 16.0M | 18.4M | 19.3M | |
Total Revenue | 145.5M | 485.5M | 1.0B | 1.3B | 1.5B | 1.5B | |
Gross Profit | 4.5M | 243.7K | (95.0M) | 31.6M | 28.5M | 29.9M | |
Operating Income | (39.5M) | (35.1M) | (1.6B) | (167.9M) | (151.1M) | (158.6M) | |
Ebit | (28.9M) | (187.9M) | (1.5B) | (167.7M) | (151.0M) | (158.5M) | |
Ebitda | (39.0M) | (28.1M) | (1.5B) | (81.1M) | (73.0M) | (76.6M) | |
Income Before Tax | (42.0M) | (45.4M) | (1.6B) | (183.7M) | (165.4M) | (173.6M) | |
Net Income | (42.0M) | (31.4M) | (270.1M) | (57.8M) | (52.0M) | (54.6M) | |
Income Tax Expense | 2.6M | (4.0M) | 1.9M | 2.7M | 3.1M | 3.3M | |
Minority Interest | 7.9M | 4.3M | 1.3B | 523.3M | 601.8M | 403.2M |
P3 Health Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Investments | (3.9M) | (3.2M) | (7.7M) | (2.0M) | (2.3M) | (2.4M) | |
Change In Cash | 7.0M | 100.9M | (122.4K) | 22.5M | 25.8M | 29.5M | |
Free Cash Flow | (29.7M) | (27.5M) | (128.3K) | (77.9M) | (70.1M) | (66.6M) | |
Depreciation | 795.2K | 8.7M | 87.3K | 86.7M | 99.7M | 104.7M | |
Other Non Cash Items | (1.6M) | 7.0M | 1.3M | 15.9M | 18.3M | 19.3M | |
Capital Expenditures | 2.9M | 3.4M | 2.2K | 1.8M | 1.6M | 1.7M | |
Net Income | (45.4M) | (156.5M) | (1.6M) | (57.8M) | (52.0M) | (54.6M) |
PIII Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining P3 Health's current stock value. Our valuation model uses many indicators to compare P3 Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across P3 Health competition to find correlations between indicators driving P3 Health's intrinsic value. More Info.P3 Health Partners is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, P3 Health's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the P3 Health's earnings, one of the primary drivers of an investment's value.P3 Health Partners Systematic Risk
P3 Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. P3 Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on P3 Health Partners correlated with the market. If Beta is less than 0 P3 Health generally moves in the opposite direction as compared to the market. If P3 Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one P3 Health Partners is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of P3 Health is generally in the same direction as the market. If Beta > 1 P3 Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in P3 Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various P3 Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of P3 Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
P3 Health March 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of P3 Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of P3 Health Partners. We use our internally-developed statistical techniques to arrive at the intrinsic value of P3 Health Partners based on widely used predictive technical indicators. In general, we focus on analyzing PIII Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build P3 Health's daily price indicators and compare them against related drivers.
Information Ratio | (0.02) | |||
Maximum Drawdown | 28.7 | |||
Value At Risk | (5.88) | |||
Potential Upside | 9.52 |
Complementary Tools for PIII Stock analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Valuation Check real value of public entities based on technical and fundamental data |